By continuing to browse this site, you agree to our use of cookies. Read our privacy policy

Consultant - WHO Private sector engagement to improve access to NCD treatment and care

Anywhere

  • Organization: WHO - World Health Organization
  • Location: Anywhere
  • Grade: Consultancy - International Consultant - Internationally recruited Contractors Agreement
  • Occupational Groups:
    • Public Health and Health Service
    • Development Cooperation and Sustainable Development Goals
    • Sustainable trade and development
    • Malaria, Tuberculosis and other infectious diseases
    • Public, Private Partnership
    • Sustainable Business Development
  • Closing Date: Closed

Purpose of consultancy

To provide technical expertise to the NCD department/ Integrated Service Delivery (ISD) Unit in its activities for improving access to NCD medicines and health products for NCD prevention and control services.

Background

The 13th General Programme of Work (GPW13) 2019-2023 adopted by WHO Member States identifies an approach to effectively strengthen national health systems, support countries to reach universal health coverage (UHC), and advance the 2030 Agenda to achieve the Sustainable Development Goals (SDGs). Over the period 2019-2022, the ‘Health Systems Strengthening for Universal Health Coverage’ Partnership (HSS for UHC) aims to address and strengthen key health systems components with a particular focus on NCD and health security at national and regional levels in the African, Caribbean and Pacific (ACP) group of states but also in other regions.

WHO is convening a series of global dialogues with representatives from international business associations and private sector entities, representing the food and non-alcoholic beverage industries, pharmaceutical industries, sport industries, and economic operators in the area of alcohol production and trade. These dialogues focus on mobilizing commitments and contributions by the private sector towards national NCD responses to achieve sustainable development goal (SDG) 3.4, 3.8, 3b.

The Global Diabetes Compact (GDC) was launched on 14 April 2021 as a WHO-led multi-stakeholder initiative with the vision of a world where the risk of diabetes is reduced and where all people who are diagnosed with diabetes have access to equitable, comprehensive, affordable and quality treatment and care. To deliver on this vision and support countries in the achievement of diabetes and the related SDG targets, the Secretariat has set up six workstreams engaging departments across WHO and external stakeholders, with workstream 1 aimed at improving access to diabetes medicines and health technologies.

Part of the workstream implementation, includes convening biannual private sector dialogues with representatives from international business associations and the pharmaceutical and health technology industry. The dialogues focus on mobilizing commitments and contributions by the private sector toward the noncommunicable diseases (NCDs) response to achieve SDG target 3.4, 3.8 and 3b by improving access and affordability of safe, effective, and quality diabetes and other NCD medicines and associated health technology products.

WHO will expand its mandate with the pharmaceutical and health technology industry to hypertension dialogues early in 2022, and potentially cancer. The aim of these dialogues will be for industry and other key stakeholders to discuss commitments and contributions to improve access to hypertension medicine and health technologies for low- and middle-income countries.

Deliverables

Output 1. Provide technical support to the private sector dialogue with pharmaceutical and health technology industry.
Deliverable 1.1. Develop pre-reads and WHO documents for the organization of the hypertension dialogues with the pharmaceutical and health technology industry.
Expected by February 2022

Deliverable 1.2. Landscape document of medicines, health technologies and stakeholders for the hypertension dialogues
Expected by February 2022

Deliverable 1.3. Participate in the hypertension dialogues and bilateral meetings with stakeholders and prepare draft meeting reports from the dialogue on hypertension.
Expected by March 2022

Output 2. Facilitate the access to diabetes medicine and health technologies as part of the Global Diabetes Compact workstream 1.
Deliverable 2.1. Collaborate with the implementing partners on a case building document for the licensing of SGLT2 inhibitors to accelerate access to affordable generic versions in LMICs, including a credible narrative on expanding access as part of the Global Diabetes Compact.
Expected by February 2022

Deliverable 2.2. Develop briefing notes, presentations and background documents for workstream 1 of the Global Diabetes Compact to support efforts at making SGLT2 inhibitors available, affordable and accessible in LMICs with an initial focus on supporting voluntary licensing and affordable price points.
Expected by March 2022

Deliverable 2.3. Collaborate with the team lead on the access barriers to human and analogue insulins, and develop a scenario document on market shaping strategies for improved access.
Expected by March 2022

Qualifications, experience, skills and languages

Educational Qualifications:

Essential:

Advanced University degree in public health, pharmacy, policy development or law.

Experience

Essential:

At least 5 years experience in global health policy, reforms or innovation and access to medicines

Desirable:

  • Experience in working with the private sector
  • Experience in UN, development agencies or international NGOs

Skills/Knowledge:

  • A substantive track record of policy analysis of the existing public health policies and approaches to ensuring access to health technologies
  • Strong interpersonal skills and ability to communicate credibly within peer community
  • Knowledge of public health, practices, programmatic implementation and related subject
  • Excellent knowledge of Microsoft Office applications

Languages required:

Essential:

Expert knowledge of English

Location

Home based – Off-site

Travel

The consultant is not expected to travel.

Remuneration and budget (travel costs are excluded):

Remuneration:

Payband level B
USD 7,000 – 9,980 per month

Living expenses (A living expense is payable to on-site consultants who are internationally recruited):

N/A

Expected duration of contract:

3 months
Start date: 10/01/2022 - End date: 08/04/2022

Additional Information

  • This vacancy notice may be used to identify candidates for other similar consultancies at the same level.
  • Only candidates under serious consideration will be contacted.
  • A written test may be used as a form of screening.
  • If your candidature is retained for interview, you will be required to provide, in advance, a scanned copy of the degree(s)/diploma(s)/certificate(s) required for this position. WHO only considers higher educational qualifications obtained from an institution accredited/recognized in the World Higher Education Database (WHED), a list updated by the International Association of Universities (IAU)/United Nations Educational, Scientific and Cultural Organization (UNESCO). The list can be accessed through the link: http://www.whed.net/. Some professional certificates may not appear in the WHED and will require individual review.
  • For information on WHO's operations please visit: http://www.who.int.
  • WHO is committed to workforce diversity.
  • WHO has a smoke-free environment and does not recruit smokers or users of any form of tobacco.
  • Applications from women and from nationals of non and underrepresented Member States are particularly encouraged.
  • WHO prides itself on a workforce that adheres to the highest ethical and professional standards and that is committed to put the WHO Values Charter into practice.
  • WHO has zero tolerance towards sexual exploitation and abuse (SEA), sexual harassment and other types of abusive conduct (i.e., discrimination, abuse of authority and harassment). All members of the WHO workforce have a role to play in promoting a safe and respectful workplace and should report to WHO any actual or suspected cases of SEA, sexual harassment and other types of abusive conduct. To ensure that individuals with a substantiated history of SEA, sexual harassment or other types of abusive conduct are not hired by the Organization, WHO will conduct a background verification of final candidates.
  • Consultants shall perform the work as independent contractors in a personal capacity, and not as a representative of any entity or authority. The execution of the work under a consultant contract does not create an employer/employee relationship between WHO and the Consultant.
  • WHO shall have no responsibility whatsoever for any taxes, duties, social security contributions or other contributions payable by the Consultant. The Consultant shall be solely responsible for withholding and paying any taxes, duties, social security contributions and any other contributions which are applicable to the Consultant in in each location/jurisdiction in which the work hereunder is performed, and the Consultant shall not be entitled to any reimbursement thereof by WHO.
  • Consultants working in Switzerland must register with the applicable Swiss cantonal tax authorities and social security authorities, within the prescribed timeframes (Guidelines issued by the Swiss Mission are available at: https://www.eda.admin.ch/missions/mission-onu-geneve/en/home/manual-regime-privileges-and-immunities/introduction/Manuel-personnes-sans-privileges-et-immunites-carte-H/Non fonctionnaires et stagiaires.html
This vacancy is now closed.
However, we have found similar vacancies for you: